Posttransplantation Systemic Immunomodulation with SA-FasL–Engineered Donor Splenocytes Has Robust Efficacy in Preventing Cardiac Allograft Rejection in Mice

Benzer Materyaller

• Immunomodulation With SA-FasL Protein as an Effective Means of Preventing Islet Allograft Rejection in Chemically Diabetic NOD Mice
  Yazar:: Yolcu, E.S., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Induction of Tolerance to Cardiac Allografts Using Donor Splenocytes Engineered to Display on Their Surface an Exogenous FasL Protein
  Yazar:: Yolcu, Esma S., ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Pancreatic Islets Engineered with SA-FasL Protein Establish Robust Localized Tolerance by Inducing T Regulatory Cells in Mice
  Yazar:: Yolcu, Esma S, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege
  Yazar:: Woodward, Kyle Blake, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• FasL Expression in Hepatic Antigen-Presenting Cells and Phagocytosis of Apoptotic T Cells by FasL(+) Kupffer Cells Are Indicators of Rejection Activity in Human Liver Allografts
  Yazar:: Miyagawa-Hayashino, Aya, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)